Clinical Trial Update: Comparison of Psyllium and Microcrystalline Cellulose on Glycemic Measures in Subjects With Impaired Fasting Glucose [NA]

View source ↗

Summary

A completed clinical trial comparing psyllium and microcrystalline cellulose on glycemic measures in adults with impaired fasting glucose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose

Drugs mentioned

• Microcrystalline cellulose (Microcrystalline cellulose)
• Psyllium (psyllium)

Snippet

Sponsor: Procter and Gamble | Conditions: Impaired Fasting Glucose | NA | Status: COMPLETED